1Y Close · As of Aug 26, 2026
Keeps Biopharma operates in the Pharmaceuticals sector.
Legal name: Keeps Biopharma Inc.
In fiscal year 2025, Keeps Biopharma (256940) reported revenue of 170.1 billion KRW, up 33.4% from 127.6 billion KRW a year earlier.
Operating profit was 1.6 billion KRW and net income was -10.4 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 115.9 billion KRW, with a P/B of 1.42.
These figures can be verified in the DART filing (receipt no. 20260323000346).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 170.1B | 1.6B | -10.4B |
| 2024 | 127.6B | 6.2B | 1.6B |
| 2023 | 92.1B | 3.1B | 3.5B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-18 | Derivative Trading Loss |
| 2026-08-14 | Semi-Annual Report (2026.06) |